Labor and cost requirements of two commercial assays for qualitative molecular detection of hepatitis C virus.
J Clin Microbiol, 2002/9;40(9):3476-7.
Schrijver I[1], Baron EJ
Affiliations
PMID: 12202596
Impact factor: 11.677
Abstract
The Bayer transcription-mediated amplification (TMA) and the Roche PCR Amplicor version 2.0 molecular assays for the qualitative detection of hepatitis C virus were compared for cost, hands-on time, assay duration, and complexity. The TMA assay compares well to PCR and may be especially useful for laboratories with large numbers of test requests.
MeSH terms
Costs and Cost Analysis; Health Workforce; Hepacivirus; Hepatitis C; Humans; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; RNA, Viral; Reagent Kits, Diagnostic; Time Factors; Transcription, Genetic; Viral Load
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download